Robertson Microlit Laboratories, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1705 U.S. Highway 46 Suite 1D, Ledgewood, New Jersey (NJ) 07852, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 2246982 · DUNS 177250289
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2024-01-11
- NAIDrug Quality Assurance2017-03-23
- VAIDrug Quality Assurance2014-09-09
- NAIDrug Quality Assurance2011-12-20
- NAIDrug Quality Assurance2010-01-20
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- amifampridine phosphateCatalyst Pharmaceuticals, Inc.
- dordaviproneJazz Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.